Lawsuitsettlementnews.com Says Xarelto Lawsuits Rise as Court Begins Process to Select Cases for Initial Bellwether Trials
Lawsuit Website also announces that they have secured capital for Xarelto funding, and are able to provide assistance for Xarelto bleeding victims who are looking for attorneys.
NEW ORLEANS, Jan. 18, 2016 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, reports today that Xarelto lawsuits have risen to approximately 2,400 cases against Bayer and Johnson & Johnson's Janssen Pharmaceutical Division as the court has started the process of selecting cases for the initial bellwether trials. 40 cases will be selected for the Xarelto multidistrict litigation bellwether trial pool. The Xarelto multidistrict litigation (MDL) is currently underway in the U.S. District Court in the Eastern District of Louisiana. A court order instructed both the plaintiffs and defense to each select 10 cases for the pool by January 11th, five from the Eastern District of Louisiana, one from Mississippi, one from Texas, and three from other states. The court order also asked the parties to try to choose at least one case from six different injury categories. The injury categories include gastrointestinal bleed, brain bleed/hemorrhagic stroke, and rectal bleeding, and the court order is requesting cases of individuals who suffered these injuries while using Xarelto to prevent stroke, as well as individuals who used Xarelto to treat pulmonary embolism or deep vein thrombosis. Additionally, they had to select an additional 20 lawsuits by January 15th including 10 cases from Louisiana, two from Mississippi, and one case each from eight other states. Four bellwether trials are set to begin in February of 2017. The first two trials are set to take place in the Eastern District of Louisiana on February 6th, 2017 and March 13th, 2017. The third and fourth trials will take place in Mississippi and Texas on April 24th, 2017 and May 30th, 2017.
Court records now indicate that approximately 2,400 Xarelto cases are pending in the Eastern District of Louisiana against Xarelto's maker, Bayer and Johnson & Johnson's subsidiary, Janssen Pharmaceutical Division. The lawsuits have similar allegations, claiming serious health problems, long hospital stays, and even death as a result of uncontrollable bleeding events due to Xarelto usage. There is no known antidote at this time. MTS also announced today that they have secured large capital for Xarelto funding. They are also reporting that they are able to provide assistance for Xarelto bleeding victims, or their loved ones, who are in need of an attorney.
MTS encourages anyone who is looking for lawsuit funding on their Xarelto or Pradaxa case, or anyone looking for assistance with finding a Xarelto or Pradaxa law firm or lawyer, to contact the company immediately for assistance. If you, or a loved one, need assistance, please visit the company's website at http://www.lawsuitsettlementnews.com/pradaxa-all-blood-thinner-cases for more information.
Chris Janish, CEO of MTS, commented on the recent announcement, "We urge victims or their family members who have been hospitalized due to uncontrollable bleeding events while taking Xarelto to contact us as the litigation is picking up steam and time is running out to file a claim. We are able to connect people with some of the most highly recognized Xarelto law firms that we work with to assist them with their cases."
If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News can help you. Victims of Pradaxa or Xarelto usage and complications can apply for up to $50K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: http://www.lawsuitsettlementnews.com/about-our-products-and-services
If you, or a loved one, have been injured by Xarelto or Pradaxa and need lawsuit money or lawsuit help, including finding a Xarelto or Pradaxa law firm, and would like to speak with a live agent who can answer any questions you may have, please call: 877.571.0405.
You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly.
Disclaimer: MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page.
Contact: Chris Janish, CEO
Ph. 877.571.0405
SOURCE MT Services LLC
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article